Sequence vs Calibrate: GLP-1 Weight Loss Programs Compared (2026)
An independent, side-by-side comparison of Sequence and Calibrate for GLP-1 weight loss programs — pricing, medications, protocols, and patient experience.

Quick Verdict
Best Price
Calibrate
Starting at $25/mo vs $99/mo
Most Medications
Sequence
2 medications vs 2
Best for Beginners
Sequence
Hybrid, fast onboarding
Head-to-Head Comparison
Pricing Breakdown
Side-by-side pricing for every medication.
| Medication | Sequence | Calibrate | Savings |
|---|---|---|---|
| Semaglutide | $99/monthly | $25/monthly | Save $74/mo with Calibrate |
| Tirzepatide | Not offered | $299/monthly | Only at Calibrate |
Pros and Cons
Sequence
- Founded by obesity medicine specialists
- Insurance-first approach can save patients hundreds per month on brand-name GLP-1 medications
- Video consultations with experienced clinicians, not just questionnaire-based async reviews
- Prior authorization and insurance appeals support included in membership
- Personalized titration managed through follow-up video visits
- Higher total cost for cash-pay patients
- The $99/month membership is charged on top of medication costs (unlike all-inclusive platforms)
- No published independent outcomes data for their patient population
- Insurance navigation success varies
- Less established brand than Hims or Ro
Calibrate
- Comprehensive metabolic health program (not just medication)
- Lab testing and metabolic panels included
- Video consultations with obesity medicine specialists
- Works with insurance to cover GLP-1 medication costs
- Focus on sustainable weight loss and metabolic reset
- Higher program cost ($299/mo for coaching + medication separate)
- One-year commitment required
- Insurance coverage for medication not guaranteed
- Not available in all states
How They Compare
Our editorial assessment across key dimensions.
In-Depth Comparison
By sarah-chen · Last updated April 14, 2026
Sequence vs Calibrate: GLP-1 Weight Loss Programs Compared
Sequence and Calibrate are both premium-tier GLP-1 programs that specialize in getting brand-name medications covered by insurance. But they have different priorities: Sequence is an insurance-navigation platform that happens to provide a medical program, while Calibrate is a year-long behavioral program that happens to navigate insurance. The distinction matters for what you'll actually get out of each.
Quick Verdict
| Sequence | Calibrate | |
|---|---|---|
| Monthly cost | ~$99/month + medication cost | ~$249–$299 one-time program fee + medication |
| Best for | Insurance-first patients wanting specialist advocacy | Patients wanting a structured year-long program |
| Weakest point | Medication cost still passes through insurance | High upfront program fee |
| Insurance navigation | Core specialization | Included in program |
| Coaching depth | Moderate | Deep (RD + behavioral health) |
| Compounded fallback | Yes | Limited |
Pricing Structure
The cost models differ significantly — this is the most important comparison for most patients.
Sequence Pricing
- Program fee: ~$99/month (covers medical visits, provider access, insurance advocacy)
- Medication cost: Passes through your insurance (with copay assistance); compounded semaglutide available at ~$149–$249/month if insurance fails
- Who pays less: Patients with insurance that covers GLP-1s — net cost can be $99 + $0–$50 copay
- Who pays more: Patients without coverage (pay $99 + full medication cost)
Calibrate Pricing
- Program fee: ~$249–$299 (one-time, covers the full year-long program)
- Medication cost: Passes through your insurance; Calibrate helps navigate prior authorization
- What's included: Year-long curriculum, dietitian coaching, behavioral health support, medical team access
- Who pays less: Patients who want a structured year-long program; the per-month cost works out to ~$25/month amortized over 12 months
- Who pays more: Anyone who doesn't complete the full program year
| Cost Component | Sequence | Calibrate |
|---|---|---|
| Program/membership | ~$99/month | ~$249–$299 one-time |
| Brand-name medication (with coverage) | Copay (~$0–$50 with savings card) | Copay (~$0–$50 with savings card) |
| Brand-name medication (no coverage) | ~$149–$249/month compounded | Limited compounded option |
| Approximate 12-month total (with insurance) | ~$1,200+ | ~$600–$800+ |
Insurance Navigation: The Core Differentiator
Both platforms help with prior authorization and insurance appeals — but the approach differs.
Sequence's Approach
Sequence was built around insurance navigation as a primary service. The clinical team is experienced in the prior authorization process, documentation requirements, and appeals. Sequence providers write medical necessity letters and actively work appeals for denied claims. The platform tracks insurance outcomes and understands which plans have the best GLP-1 formularies.
Best for: Patients who have insurance that might cover GLP-1s and need specialist advocacy to get it approved.
Calibrate's Approach
Calibrate's program includes insurance navigation as a component of the broader program, not the primary service. The Calibrate team helps with prior authorization documentation and the appeals process. However, insurance advocacy is a supporting function rather than the core platform capability.
Best for: Patients who want a comprehensive program and insurance navigation as part of it, rather than patients who need intensive insurance advocacy as the primary service.
Program Depth and Coaching
| Feature | Sequence | Calibrate |
|---|---|---|
| Registered Dietitian access | Yes (on-demand) | Yes (scheduled, ongoing) |
| Behavioral health support | Limited | Yes — included |
| Medical provider check-ins | Regular | Regular |
| Structured curriculum | Moderate | Full year-long curriculum (4 pillars) |
| Peer community | Limited | Yes |
| Exercise guidance | General | Yes — structured |
| Sleep and metabolic tracking | Limited | Yes — Calibrate's 4-pillar model |
Calibrate's 4-Pillar model covers food, sleep, exercise, and emotional health — all explicitly tracked as part of the program. The behavioral health component (included at no additional cost) is unusual for a telehealth GLP-1 platform.
Sequence's coaching is solid but less structured. You have provider access and dietitian consultations, but there is no required year-long curriculum.
Medication Flexibility
| Medication | Sequence | Calibrate |
|---|---|---|
| Brand-name Wegovy (semaglutide) | Yes, through insurance | Yes, through insurance |
| Brand-name Zepbound (tirzepatide) | Yes, through insurance | Yes, through insurance |
| Compounded semaglutide (fallback) | Yes — $149–$249/month | Limited |
| Tirzepatide (compounded) | Limited | No |
Sequence has more flexibility when insurance doesn't work — they can pivot to compounded medication. Calibrate's program is more insurance-dependent, so patients whose coverage falls through have fewer options within the platform.
Head-to-Head: Who Should Choose Which
Choose Sequence if:
- Your primary goal is getting brand-name GLP-1 coverage approved by insurance
- You want monthly flexibility (no large upfront program commitment)
- You need a fallback to compounded medication if insurance fails
- You want active insurance advocacy as the core service
- You don't want or need a year-long structured behavioral curriculum
Choose Calibrate if:
- You want a comprehensive year-long program with behavioral depth
- Behavioral health and emotional eating are important components to address
- You have insurance that likely covers GLP-1s and need the program more than the advocacy
- You're committed to a full-year engagement with a structured curriculum
- The dietitian + behavioral health + medical team combination appeals to you
The Insurance Reality Check
Before choosing either platform on the basis of insurance navigation, verify your plan's current GLP-1 coverage status:
- Call your insurer and ask specifically: "Does my plan cover Wegovy or Zepbound for obesity treatment?" (not diabetes)
- Check your formulary — the drug list your insurer provides
- Know your deductible status — even covered GLP-1s can be expensive until your deductible is met
Many commercial insurance plans now cover at least one GLP-1 for obesity. Medicare Part D coverage expanded in 2026. If your plan already covers it with low prior auth barriers, either platform's insurance navigation service adds less marginal value.
Alternatives to Consider
| Provider | Why Consider | Monthly Cost |
|---|---|---|
| FORM Health | Board-certified obesity medicine specialists; deep insurance navigation | $149+ |
| Ro | No insurance, fast start, tirzepatide access | $149/month |
| Henry Meds | Fastest start, tirzepatide, $129 after 6 months | $149/month |
| Found | Multi-medication approach including non-GLP-1 options | $99+ |
Related Resources
- Best GLP-1 with Insurance — platforms ranked for insurance navigation
- Best GLP-1 with Coaching — programs ranked by coaching depth
- FORM Health vs Calibrate — another premium-tier comparison
- GLP-1 Insurance Coverage Guide — getting your insurance to pay
- How Much Weight Can You Lose on GLP-1 — realistic expectations
Related Guides
Best Telehealth Providers for Tirzepatide 2026: Ranked by Price and Care
The best telehealth providers for tirzepatide in 2026, ranked by price, protocol, and care quality. From $278/month compounded to brand Zepbound via insurance. No provider paid for placement.
Read guide →Is Compounded Semaglutide Legal and Safe in 2026?
Is compounded semaglutide still legal? We break down the current FDA rules, 30 new warning letters, SAFE Drugs Act, Hims exiting compounded, and what this means for your prescription.
Read guide →Compounded Tirzepatide 2026: What's Happening and What Patients Should Do
Compounded tirzepatide is under active FDA enforcement as of March 2026 — supply is declining but not yet at zero. The 503B enforcement discretion ended over a year ago (March 2025); the FDA has now issued 50+ warning letters including a 30-letter batch in March 2026. Here's what patients need to know and what to do.
Read guide →